The combination of In Vitro Fertilization (IVF) with Preimplantation Genetic Testing for Aneuploidies (PGT-A) is an advanced tool that not only improves pregnancy rates but also allows the identification of chromosomally normal embryos before being transferred to the uterus.
This genetic test offers important benefits: it enables the determination of the embryo’s sex and the detection of chromosomal abnormalities responsible for genetic syndromes such as Down syndrome (trisomy 21), Patau syndrome (trisomy 13), Edwards syndrome (trisomy 18), Klinefelter syndrome (XXY), among others.
At Advanced Fertility Center Cancún, we offer this technology to our patients as part of our commitment to cutting-edge reproductive medicine.
Medications are used to stimulate the follicles in a woman’s ovaries with the aim of obtaining the largest number of eggs.
The eggs are collected using ultrasound-guided aspiration in the operating room.
The sperm are trained to fertilize.
The oocytes are fertilized to create embryos in the laboratory: conventional IVF or ICSI (intracytoplasmic sperm injection).
A biopsy of the trophectoderm or outer layer of embryos at the blastocyst stage (day 5-6 of development) is performed.
The embryos are vitrified (frozen) for storage and transfer after obtaining the results of the genetic study (PGT).
